Results 171 to 180 of about 200,795 (317)
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Successful treatment of a case of paraganglioma presenting Takotsubo syndrome. [PDF]
Zhu R, Liu H, Han W, Zhang M.
europepmc +1 more source
Receptor‐induced Kv7/M‐current suppression increases neuronal activity and contributes to pathology of several conditions. A new class of Kv7 modulators identified in this study attenuates M‐current suppression and shows therapeutic effects. Abstract Background and Purpose Neuronal Kv7 channels generate low voltage–gated potassium currents known as the
Young Woo Kim +5 more
wiley +1 more source
Az adrenerg mechanizmusok szerepe és jelentősége a terhes patkány cervix és corpus összehangolt működésének szabályozásában = Role and significance of adrenergic mechanisms in the control of aligned function of pregnant rat cervix and corpus [PDF]
György Falkay +5 more
openalex
Cardiotoxicity of BRAF/MEK inhibitors
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe +4 more
wiley +1 more source
Neural regulation of bone: from central neural circuits to peripheral innervation of the skeletal stem cell niche. [PDF]
Chen Z +4 more
europepmc +1 more source
Chemokine (C-X-C Motif) Receptor 4 and Atypical Chemokine Receptor 3 Regulate Vascular α1-Adrenergic Receptor Function [PDF]
Harold H. Bach +7 more
openalex +1 more source
Abstract Background and Purpose Aberrant activation of type 2 ryanodine receptors (RyR2) causes lethal arrhythmias, such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Developing drugs that suppress RyR2 hyperactivation may be key to novel arrhythmia treatments.
Nagomi Kurebayashi +29 more
wiley +1 more source

